Cystic fibrosis (CF) is the most common lethal genetic disease in the Caucasian population,
and should be considered an infectious disease because of the basic pathophysiology …

Microbial communities characterize the airways of cystic fibrosis (CF) patients. Members of
these diverse and dynamic communities can be thought of as pathogens, benign …

The chronic colonization of the lower airways by bacterial pathogens is the leading cause of
morbidity and mortality in patients with cystic fibrosis (CF). Pseudomonas aeruginosa is the …

A comprehensive understanding of airway infections offers the potential for improved
disease management in CF patients. Accurate quantitative microbiology will be a …

Chronic suppurative lower airway infection is a hallmark feature of cystic fibrosis (CF).
Decades of experience in clinical microbiology have enabled the development of improved …

Although survival of individuals with cystic fibrosis (CF) has been continuously improving for
the past 40 years, respiratory failure secondary to recurrent pulmonary infections remains …

Historically, H. influenzae and S. aureus were considered to be the primary organisms
infecting the airways of infants and children with CF, followed by P. aeruginosa or …

The genetic disease cystic fibrosis (CF) is associated with chronic airway infections that are
a proximal cause of death in many patients with this affliction. Classic microbiology studies …

Despite significant advances in treatment strategies targeting the underlying defect in cystic
fibrosis (CF), airway infection remains an important cause of lung disease. In this two-part …

Repeated pulmonary exacerbation and progressive lung function decline characterize cystic
fibrosis (CF) disease, and represents one of the leading causes of mortality in this patient …